NSAIDs
Tailoring OTC analgesic recommendations to individual patient needs
Pharmacists have an important role in helping to assess the suitability and choice of formulation of OTC analgesics for each patient, taking into account the patient’s age, medical conditions, and …
Research Roundup
Debbie Rigby takes a look at the latest research Practical guidance for stopping glucocorticoids Effective management of glucocorticoid discontinuation requires a careful approach to avoid adrenal insufficiency and withdrawal symptoms, …
Research Roundup
Debbie Rigby rounds up the latest in research news Does coprescribing nonsteroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism? When OACs are …
Research Roundup
Debbie Rigby rounds up the latest in research news NSAIDs for heavy menstrual bleeding NSAIDs used just before and during menses reduce relative mean menstrual blood loss by about 30%, …
Research Roundup
Debbie Rigby takes a look at the latest in research news Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure The EMPEROR-Reduced Trial compared empagliflozin (10 mg once daily) or …
Ibuprofen advice
People are still concerned about the use of ibuprofen to treat COVID-19 symptoms, says NPS MedicineWise The organisation has added new information to its website about the medicine, after concerns …
Ibuprofen not linked to worse outcomes
Organisations including the TGA have moved to reassure Australians that there is no association between using NSAIDs like ibuprofen, and worse COVID-19 outcomes The TGA said on Friday that it …
Research Roundup
SGLT2 inhibitors, NSAIDs, budesonide-formoterol reliever therapy and medication review in RACFs SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes A systematic review of 4 …
Research Roundup
Debbie Rigby rounds up the latest in research news Reduction in Use of Risperidone for Dementia in Australia Risperidone is the only antipsychotic approved in Australia for the management of …
Pharmacy-only NSAIDs: is it time?
Stakeholders have suggested that NSAIDs could be moved to pharmacy-only in a bid to avoid interactions such as the “triple whammy” with diuretics and ACE inhibitors Macquarie University researcher Dr …
Research Roundup
Debbie Rigby takes a look at the latest in research news Risks and benefits of direct oral anticoagulants versus warfarin In this large prospective cohort study apixaban was found to …
Research Roundup
Debbie Rigby takes a look at the latest in research news Effect of cannabis use in people with chronic non-cancer pain prescribed opioids Findings from a 4 year prospective Australian …